Comparison of Four Early Posttherapy Imaging Changes (EPTIC; RECIST 1.0, Tumor Shrinkage, Computed Tomography Tumor Density, Choi Criteria) in Assessing Outcome to Vascular Endothelial Growth Factor–Targeted Therapy in Patients With Advanced Renal Cell Carcinoma
Katherine M. Krajewski(Brigham and Women's Hospital), Mengye Guo(Dana-Farber Cancer Institute), Annick D. Van den Abbeele(Dana-Farber Cancer Institute), Jeffrey T. Yap(Brigham and Women's Hospital), Nikhil H. Ramaiya(Dana-Farber Cancer Institute), Jyothi P. Jagannathan(Dana-Farber Cancer Institute), Daniel Y.C. Heng, Michael B. Atkins(Beth Israel Deaconess Medical Center), David F. McDermott(Beth Israel Deaconess Medical Center), Fabio A. Schutz(Dana-Farber Cancer Institute), Iván Pedrosa(Beth Israel Deaconess Medical Center), Toni K. Choueiri(Dana-Farber Cancer Institute)
Cited by 112
Abstract
Related Papers
No related papers found
Powered by citation graph analysis